Merck and Moderna release promising data on cancer vaccine trial NPRBreakthrough vaccine for the deadliest skin cancer cut risk by almost half The Washington PostFirst-of-Its-Kind Vaccine Ushers in New Hope for Cancer Patients The New York TimesPersonalized mRNA vaccine for melanoma cut risk of cancer’s return in late-stage trial NBC NewsModerna’s Cancer Vaccine Success Doesn’t Live Up to Early Hype WSJ
